Kendall Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$716K Sell
619
-200
-24% -$236K 0.12% 143
2026
Q2
$982K Sell
819
-600
-42% -$613K 0.16% 131
2026
Q1
$1.31M Buy
+1,419
New +$1.44M 0.27% 93

Other funds holding LLY

Kendall Capital Management's LLY Position: Q3 2026 in Review

Kendall Capital Management reduced its Eli Lilly (LLY) stake by 24% in Q3 2026, selling an estimated $236K and leaving 619 shares worth $716K. The position accounts for 0.12% of the portfolio, ranked #143.

Kendall Capital Management first reported a position in LLY in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.31M in Q1 2026. 3,244 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Kendall Capital Management held 619 shares of Eli Lilly worth $716K as of Q3 2026.
  • Kendall Capital Management sold 200 Eli Lilly shares in Q3 2026, an estimated $236K.
  • Eli Lilly made up 0.12% of Kendall Capital Management's portfolio in Q3 2026, its #143 holding.
  • Kendall Capital Management first reported a position in Eli Lilly in Q1 2026 and has held it in 3 quarters since.
  • Kendall Capital Management's Eli Lilly position peaked at $1.31M in Q1 2026.
  • 3,244 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Kendall Capital Management's 13F filing for Q3 2026, filed 23 Oct 2026.